关注今日：7 | 主题：566595
微信扫一扫
【求助】PLOS one通讯作者问题
页码直达：
这个帖子发布于2年零4天前，其中的信息可能已发生改变或有所发展。
本人投稿至PLOS ONE，如果把老板加为通讯作者，必须得用老板的邮箱和账号，这个能不能先把自己作为通讯作者，等论文接收后再修改通讯作者为老板，不知道这种方案可行吗？好不好操作，需要注意什么？我看网上有人这么做，不知道现在的情况，谢谢！另外，我需要挂两个单位，前面投稿系统中怎么加两个单位,能跟通讯作者一样，系统中填一个，提交稿中填两个可以吗？这里吐槽一下，因为毕业答辩前需要论文刊出，所以不得不投PLOS one，但发现这个收费如此高的期刊，投稿系统弱爆了
不知道邀请谁？试试他们
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
收起全部有料回复
丁香园准中级站友
不用，直接在投稿系统里默认自己是第一作者和通讯作者就行了，到时候文章接收后给生产部门写封邮件就行了。这个确认没问题，我弄过。理由？自己仔细再看投稿须知里说明了的，系统和文章本身的署名是两码事，互不影响。。。。。PS：不觉得plos one的投稿系统弱，你要真是把这个系统的投稿要求全部满足了，下次投其他刊物才会发现什么叫弱爆了。。。。。。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
本人投稿至PLOS ONE，如果把老板加为通讯作者，必须得用老板的邮箱和账号，这个能不能先把自己作为通讯作者，等论文接收后再修改通讯作者为老板，不知道这种方案可行吗？好不好操作，需要注意什么？我看网上有人这么做，不知道现在的情况，谢谢！答：从程序上肯定不可以。通讯作者是本文的主要负责作者，不能在投稿的时候连知情都没有，所以，如果你要你老板当通讯作者并同意你PLOS ONE，必须得到他的首肯，否则无法投稿！从理论上，你的数据版权属于他，你无权支配。另外，我需要挂两个单位，前面投稿系统中怎么加两个单位,能跟通讯作者一样，系统中填一个，提交稿中填两个可以吗？答：这是可以的，基本没有问题。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
plose one 快么？去年12月投的现在还在二次返修中。。。。。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
devil19840 本人投稿至PLOS ONE，如果把老板加为通讯作者，必须得用老板的邮箱和账号，这个能不能先把自己作为通讯作者，等论文接收后再修改通讯作者为老板，不知道这种方案可行吗？好不好操作，需要注意什么？我看网上有人这么做，不知道现在的情况，谢谢！答：从程序上肯定不可以。通讯作者是本文的主要负责作者，不能在投稿的时候连知情都没有，所以，如果你要你老板当通讯作者并同意你PLOS ONE，必须得到他的首肯，否则无法投稿！从理论上，你的数据版权属于他，你无权支配。另外，我需要挂两个单位，前面投稿系统中怎么加两个单位,能跟通讯作者一样，系统中填一个，提交稿中填两个可以吗？答：这是可以的，基本没有问题。 老板是同意的，只是投稿系统设置老板为通讯作者，需要用户名，不知道是不是还要帮他申请一个？以后操作都让他操作，好像也挺麻烦，他也嫌麻烦，他其实让我们投稿时让我们也作为共同通讯作者，但PLOS one只能一个。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
liufang7250 plose one 快么？去年12月投的现在还在二次返修中。。。。。 不知道呢 还没投
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园准中级站友
帮你老板申请一个账号，经过他同意后可以在系统里把备用email写你的，以后所有发你老板的email会自动抄送给你，就不用你老板去操作了。最后文章发了proof里就放你老板的email就可以了。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园准中级站友
不用，直接在投稿系统里默认自己是第一作者和通讯作者就行了，到时候文章接收后给生产部门写封邮件就行了。这个确认没问题，我弄过。理由？自己仔细再看投稿须知里说明了的，系统和文章本身的署名是两码事，互不影响。。。。。PS：不觉得plos one的投稿系统弱，你要真是把这个系统的投稿要求全部满足了，下次投其他刊物才会发现什么叫弱爆了。。。。。。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
我也是用自己的账号投稿的，接收前担心有问题，就发邮件和编辑沟通了，以下是她的回复，供参考：If an author is listed as the corresponding author in the manuscript, this will be the corresponding author listed in the article, handling queries from readers.
The corresponding author listed in submission form is the author responsible to act as a point of contact during the submission and pre-production process.If you wish to remain the corresponding author, you will be the source of contact for the submission. However, if you want to change the corresponding authors to Professor XX and Dr. XX, you will have to adjust this in the document, and we will update the online submission form accordingly so that they become the point of contact.
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园助理版主
一般而言，杂志的submitting author和corresponding author可以分开。除非杂志特别要求，如JCI，CNS，要求corresponding author即为submitting author。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
丁香园版主
最好用通讯作者的邮箱投稿吧，也可以用自己的投，后面再更改，但总是那么不太合规规矩。可以注明两个单位，在文章中标明就可以，但我之前是在cover letter中注明了标两个单位的原因，比如说第二单位参与了本研究，或者作者工作单位变动等。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
求大神帮助： 向PLOS ONE 投稿时，上传的manuscript稿中需要包括作者姓名，单位吗？还需要标明通讯作者（指终稿发表时的通讯作者，不是投稿时的通讯作者）？？？ 另外，关键词没有提出要求，我可以在上传的maunscript中加上关键词吗？在投稿说明里提到了关键词，但没有说要写在什么地方啊。
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
请问投稿plos one可以是两个通讯作者吗？
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
关于丁香园小木虫 --- 600万学术达人喜爱的学术科研平台
热门搜索：
&&查看话题
plos one给我发邮件了，说是找不到编辑，信的内容如下
Sample Text
I am writing to offer an update on your submission to PLOS ONE.
Unfortunately we have had a very difficult time finding an appropriate Academic Editor to handle your manuscript.&&Please accept our apologies for this delay.&&We recognize that you likely chose to submit to PLOS ONE in part because you were hoping for a swift peer review process, and we are sorry we have not been able to meet your expectations.
We will continue to try to find an Academic Editor who is available to evaluate your manuscript, but we want to alert you that this will proceed more slowly than the typical PLOS ONE submission and further delays are likely.&&Therefore, we also want to offer the opportunity to withdraw your paper from our submission system at this time and submit elsewhere if you prefer.&&Please contact us at plosone@plos.org if you would like us to help facilitate this process.
Please be aware that we may contact you again if we are unable to identify an Academic Editor for your manuscript.&&Thank you for your patience and understanding.
Best Wishes,
Publications Manager
但是没让我再次提供建议的人啊，我看之前有人发过其中让建议审稿人。我回复信说继续等待，并再次建议了审稿人。有没有遇到这样情况的小伙伴啊
什么意思啊&&撤稿吗
但是我选择了等待，我已经给编辑写信了，编辑说有消息和你联系
投稿一个月了
那后来你的怎么办了呀
我也怕这个&&等来等去找不到审稿人&&然后强行撤稿 我在等几天 元旦过后吧& &看情况
投稿一个月了&&等等看看吧& &无语啊
但是我是在十一月20几号就投稿了
投稿一个月了&&等元旦过后吧
就是啊&&都不知道等什么时候呢
嗯&&估计也是& &大家都忙过节呢& &主要是我拿来毕业呀&&先把毕业问题解决再说哈哈& &但是我在圣诞节的前一个月投稿的
学术必备与600万学术达人在线互动！
扫描下载送金币关注今日：7 | 主题：566595
微信扫一扫
【求助】求助！投稿PLOS ONE,需要大修，找不到reviewer comments！ 急急急
页码直达：
这个帖子发布于4年零152天前，其中的信息可能已发生改变或有所发展。
小弟2月9日往plos one投了文章，3月5日回来意见说要大修。以下是编辑回信。有两点疑惑，用红色标记出来了，希望大家帮忙解答一下！1.我写的文章是关于基因芯片检测唇腭裂样品方面的，按编辑部的意思我是否应该将我的芯片结果上传到他说的那几个数据库中，并且将数据库的accession number写上去。2.他说reviewer comments放在action link 的&View Attachments&里，假如没有View Attachments，就是没有附件。但是我的action link里就是没有View Attachments，只有下面几个link。View Submission File Inventory Revise Submission Decline to Revise Send E-mail那么我应该怎么修改我的论文。因为有一个reviewer说我的表达有问题，很不通畅。没有具体意见的话我要全部都改吗？还是我给编辑部发个邮件问一下就会有审稿意见了呢？不知道我要说的表达明白没有，希望有经验的来帮帮忙解答一下小弟的疑惑。谢谢。Dear Mr lu,Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit, but is not suitable for publication as it currently stands. Therefore, my decision is &Major Revision.& We invite you to submit a revised version of the manuscript that addresses the points below: We encourage you to submit your revision within forty-five days of the date of this decision. When your files are ready, please submit your revision by logging on to
and following the Submissions Needing Revision link. Do not submit a revised manuscript as a new submission. Before uploading, you should proofread your manuscript very closely for mistakes and grammatical errors. Should your manuscript be accepted for publication, you may not have another chance to make corrections as we do not offer pre-publication proofs.If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Please also include a rebuttal letter that responds to each point brought up by the academic editor and reviewer(s). This letter should be uploaded as a Response to Reviewers file.In addition, please provide a marked-up copy of the changes made from the previous article file as a Manuscript with Tracked Changes file. This can be done using 'track changes' in programs such as MS Word and/or highlighting any changes in the new document. If you choose not to submit a revision, please notify us. Yours sincerely, John G Meara, MD, DMD, MBAAcademic EditorPLOS ONEJournal requirements:When submitting your revision, we need you to address these additional requirements.1. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.2. We note that you are reporting the results of a microarray analysis.Please include the name of the repository in which you have submitted your dataset (ArrayExpress, Gene Expression Omnibus, DNA databank of Japan), and the accession number, in the methods section of your manuscript[Note: HTML markup is below. Please do not edit.]Reviewers' comments:Reviewer's Responses to QuestionsComments to the Author1. Is the manuscript technically sound, and do the data support the conclusions?The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.Reviewer #1: YesReviewer #2: YesPlease explain (optional).Reviewer #1: Yes, the manuscript is technically sound, draws on appropriate references, and the conclusions are supported.Reviewer #2: The study used a SNP microarray of 7 genes to look at the frequency in nonsyndromic cleft lip and palate in Northern China. They did find statistically significant associations with several SNPs in the IRF6 and TGFA genes. Their results do seem to be supported by the listed data.2. Has the statistical analysis been performed appropriately and rigorously?Reviewer #1: YesReviewer #2: YesPlease explain (optional).Reviewer #1: Well done study with clear statistics and appropriate conclusions.Reviewer #2: (No Response)3. Does the manuscript adhere to standards in this field for data availability?Authors must follow field-specific standards for data deposition in publicly available resources and should include accession numbers in the manuscript when relevant. The manuscript should explain what steps have been taken to make data available, particularly in cases where the data cannot be publicly deposited.Reviewer #1: YesReviewer #2: YesPlease explain (optional).Reviewer #1: (No Response)Reviewer #2: (No Response)4. Is the manuscript presented in an intelligible fashion and written in standard English?PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors below.Reviewer #1: YesReviewer #2: NoPlease explain (optional).Reviewer #1: Clearly written, especially given the highly technical nature of the methods.Reviewer #2: The manuscript is poorly written and must be edited extensively. It is difficult to read and I was not sure what some sentences meant.5. Additional Comments to the Author (optional)Please offer any additional comments here, including concerns about
or .Reviewer #1: No concerns about this study. It was well designed, the results are valid, and to my knowledge this adds to the field of cleft genetics without overlap.Reviewer #2: Additional details about why these particular genes were picked should be given. Certainly this literature to support some of these genes, but more detail should be given. In addition much more detail should be given about the subjects and the control population. How were the patients determined to be nonsyndromic? Who made this determination? Was previous genetic testing performed or was this on a clinical basis? Was there any family history of clefts, lip pits or minor anomalies? From where were the control patients obtained? What safeguards were done to ensure that there were no patients with clefts in the controls?6. If you would like your identity to be revealed to the authors, please include your name here (optional).Your name and review will not be published with the manuscript.Reviewer #1: (No Response)Reviewer #2: (No Response)[NOTE: If reviewer comments were submitted as an attachment file, they will be accessible only via the submission site. Please log into your account, locate the manuscript record, and check for the action link &View Attachments&. If this link does not appear, there are no attachment files to be viewed.]
不知道邀请谁？试试他们
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
valensu edited on
自己顶一下，来人看看吧。谢谢！
微信扫一扫
广告宣传推广
政治敏感、违法虚假信息
恶意灌水、重复发帖
违规侵权、站友争执
附件异常、链接失效
关于丁香园当前位置：
> PloS one
刊期：月刊
语种：英文
影响因子：3.73
出版国家：Public Library of Science
研究领域：生物-生物学
　　We are a nonprofit publisher and advocacy organization. Our missionis to accelerate progress in science and medicine by leading a transformation in research communication. Every article that we publish is open-access - freely available online for anyone to use. Sharing research encourages progress, from protecting the biodiversity of our planet to finding more effective treatments for diseases such as cancer.
& 　1. Format Requirements
　　PLOS ONE does not consider presubmission inquiries. All submissions should be prepared with the following files:
　　Cover letter
　　Manuscript, including tables and figure legends
　　Figures (guidelines for preparing figures can be found at the Figure and Table Guidelines)
　　Prior to submission, authors who believe their manuscripts would benefit from professional editing are encouraged to use language-editing and copyediting services. Obtaining this service is the responsibility of the author, and should be done before initial submission. These services can be found on the web using search terms like &scientific editing service& or &manuscript editing service.& Submissions are not copyedited before publication.
　　Submissions that do not meet the PLOS ONE Publication Criterion for language standards may be rejected.
　　Cover Letter
　　You should supply an approximately one page cover letter that:
　　Concisely summarizes why your paper is a valuable addition to the scientific literature
　　Briefly relates your study to previously published work
　　Specifies the type of article you are submitting (for example, research article, systematic review, meta-analysis, clinical trial)
　　Describes any prior interactions with PLOS regarding the submitted manuscript
　　Suggests appropriate PLOS ONE Academic Editors to handle your manuscript (view a complete listing of our academic editors)
　　Lists any recommended or opposed reviewers
　　Your cover letter should not include requests to reduce or waive publication fees. Should your manuscript be accepted, you will have the opportunity to include your requests at that time. See PLOS ONE Editorial Policy for more information regarding publication fees.
　　Manuscript Organization
　　PLOS ONE considers manuscripts of any length. There are no explicit restrictions for the number of words, figures, or the length of the supporting information, although we encourage a concise and accessible writing style. We will not consider monographs.
　　All manuscripts should be double-spaced and include line numbers and page numbers.
　　Manuscripts should begin with the ordered sections:
　　Authors
　　Affiliations
　　Abstract
　　Introduction
　　and end with the sections of:
　　Acknowledgments
　　References
　　Figure Legends
　　Tables
　　Figures should not be included in the main manuscript file. Each figure must be prepared and submitted as an individual file. Find more information about preparing figures here.
　　The title, authors, and affiliations should all be included on a title page as the first page of the manuscript file.
　　There are no explicit requirements for section organization between these beginning and ending sections. Articles may be organized in different ways and with different section titles, according to the authors' preference. In most cases, internal sections include:
　　Materials and Methods
　　Results
　　Discussion
　　Conclusions (optional)
　　PLOS ONE has no specific requirements for the order of these sections, and in some cases it may be appropriate to combine sections. Guidelines for individual sections can be found below.
　　Abbreviations should be kept to a minimum and defined upon first use in the text. Non-standard abbreviations should not be used unless they appear at least three times in the text.
　　Standardized nomenclature should be used as appropriate, including appropriate usage of species names and SI units.
　　Manuscript File Type Requirements
　　Authors may submit their manuscript files in Word (as .doc or .docx), LaTeX (as .pdf), or RTF format. Only RTF and .doc files can be used during the production process. Word files must not be protected.
　　LaTeX Submissions. If you would like to submit your manuscript using LaTeX, you must author your article using the PLOS ONE LaTeX template and BibTeX style sheet. Articles prepared in LaTeX may be submitted in PDF format for use during the review process. After acceptance, however, .tex files and formatting information will be required as a zipped file. Please consult our LaTeX guidelines for a list of what will be required.
　　Submissions with equations. If your manuscript is or will be in .docx format and contains equations, you must follow the instructions below to make sure that your equations are editable when the file enters production.
　　If you have not yet composed your article, you can ensure that the equations in your .docx file remain editable in .doc by enabling &Compatibility Mode& before you begin. To do this, open a new document and save as Word 97-2003 (*.doc). Several features of Word 2007/10 will now be inactive, including the built-in equation editing tool. You can insert equations in one of the two ways listed below.
　　If you have already composed your article as .docx and used its built-in equation editing tool, your equations will become images when the file is saved down to .doc. To resolve this problem, re-key your equations in one of the two following ways.
　　1. Use MathType to create the equation (recommended)
　　2. Go to Insert & Object & Microsoft Equation 3.0 and create the equation
　　If, when saving your final document, you see a message saying &Equations will be converted to images,& your equations are no longer editable and PLoS will not be able to accept your file.
　　Back to top
　　2. Guidelines for Standard Sections
　　Manuscripts must be submitted with both a full title and a short title, which will appear at the top of the PDF upon publication if accepted. Only the full title should be included in the short title will be entered during the online submission process.
　　The full title must be 250 characters or fewer. It should be specific, descriptive, concise, and comprehensible to readers outside the subject field. Avoid abbreviations if possible. Where appropriate, authors should include the species or model system used (for biological papers) or type of study design (for clinical papers).
　　Abstract
　　The abstract should:
　　Describe the main objective(s) of the study
　　Explain how the study was done, including any model organisms used, without methodological detail
　　Summarize the most important results and their significance
　　Not exceed 300 words
　　Abstracts should not include:
　　Citations
　　Abbreviations, if possible
　　Introduction
　　The introduction should:
　　Provide background that puts the manuscript into context and allows readers outside the field to understand the purpose and significance of the study
　　Define the problem addressed and why it is important
　　Include a brief review of the key literature
　　Note any relevant controversies or disagreements in the field
　　Conclude with a brief statement of the overall aim of the work and a comment about whether that aim was achieved
　　Materials and Methods
　　This section should provide enough detail to allow suitably skilled investigators to fully replicate your study. Specific information and/or protocols for new methods should be included in detail. If materials, methods, and protocols are well established, authors may cite articles where those protocols are described in detail, but the submission should include sufficient information to be understood independent of these references.
　　We encourage authors to submit detailed protocols for newer or less well-established methods as Supporting Information. Further information about formatting Supporting Information files, can be found here.
　　Methods sections of papers on research using human or animal subjects and/or tissue or field sampling must include required ethics statements. See the Reporting Guidelines for human research, clinical trials, animal research, and observational and field studies for more information.
　　Methods sections of papers with data that should be deposited in a publicly available database should specify where the data have been deposited and provide the relevant accession numbers and version numbers, if appropriate. Accession numbers should be provided in parentheses after the entity on first use. If the accession numbers have not yet been obtained at the time of submission, please state that they will be provided during review. They must be provided prior to publication. A list of recommended repositories for different types of data can be found here.
　　Methods sections of papers using cell lines must state the origin of the cell lines used. See the Reporting Guidelines for cell line research for more information.
　　Methods sections of papers adding new taxon names to the literature must follow the Reporting Guidelines below for a new zoological taxon, botanical taxon, or fungal taxon.
　　Results, Discussion, and Conclusions
　　These sections may all be separate, or may be combined to create a mixed Results/Discussion section (commonly labeled &Results and Discussion&) or a mixed Discussion/Conclusions section (commonly labeled &Discussion&). These sections may be further divided into subsections, each with a concise subheading, as appropriate. These sections have no word limit, but the language should be clear and concise.
　　Together, these sections should describe the results of the experiments, the interpretation of these results, and the conclusions that can be drawn. Authors should explain how the results relate to the hypothesis presented as the basis of the study and provide a succinct explanation of the implications of the findings, particularly in relation to previous related studies and potential future directions for research.
　　PLOS ONE editorial decisions do not rely on perceived significance or impact, so authors should avoid overstating their conclusions. See the PLOS ONE Publication Criteria for more information.
　　Acknowledgments
　　People who contributed to the work but do not fit the PLOS ONE authorship criteria should be listed in the acknowledgments, along with their contributions. You must ensure that anyone named in the acknowledgments agrees to being so named.
　　Funding sources should not be included in the acknowledgments, or anywhere in the manuscript file. You will provide this information during the manuscript submission process.
　　References
　　Only published or accepted manuscripts should be included in the reference list. Manuscripts that have been submitted but not yet accepted should not be cited. Limited citation of unpublished work should be included in the body of the text only as &unpublished data.&
　　References must be listed at the end of the manuscript and numbered in the order that they appear in the text. In the text, citations should be indicated by the reference number in brackets. Journal name abbreviations should be those found in the NCBI databases. A number of reference software companies supply PLOS style files (e.g., Reference Manager, EndNote).
由360期刊网整合发布，如有侵权请与我司联系，sci论文发表请联系客服。
期刊名称：
影响因子：复合影响因子： 1.103；综合影响因子
期刊名称：
影响因子：复合影响因子： 2.479;综合影响因子
期刊名称：
影响因子：1.961
期刊名称：
影响因子：1.608
期刊名称：
影响因子：1.606
期刊名称：
影响因子：3.677
我们保证，所有编校稿件将严格按照工作确认时确定的日期和时间交稿。如果因我们的错误导致交稿延迟，我们将免除所有费用。
知名专家专业审稿、专业修稿，确保论文的创新性、科学性、完整性；实现高速、高效与高品质的完美结合。
我们的资料保存系统与流程符合国际标准ISO认证，所有的个人与文件信息都有定制的操作流程，完全免除您的信息保存风险。
除非经客户同意，客户的姓名、电子邮箱、电话号码等个人资料均禁止让第三方取得，只有公司内部处理相关业务的员工看得到。
, All Rights Reserved 苏ICP备号}